Company Quick10K Filing
Yinghong Guangda Technology
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 42 $0
10-Q 2018-08-15 Quarter: 2018-06-30
10-Q 2018-05-21 Quarter: 2018-03-31
10-Q 2018-02-26 Quarter: 2017-12-31
10-K 2018-02-02 Annual: 2017-09-30
10-Q 2015-08-24 Quarter: 2015-06-30
10-Q 2015-05-19 Quarter: 2015-03-31
10-Q 2015-02-17 Quarter: 2014-12-31
10-K 2014-12-29 Annual: 2014-09-30
10-Q 2014-08-14 Quarter: 2014-06-30
10-Q 2014-05-13 Quarter: 2014-03-31
10-Q 2014-02-14 Quarter: 2013-12-31
10-K 2013-12-30 Annual: 2013-09-30
10-Q 2013-08-14 Quarter: 2013-06-30
8-K 2018-07-23 Accountant, Exhibits
8-K 2018-05-24 Amend Bylaw, Exhibits
8-K 2018-05-23 Officers
8-K 2018-05-11 Accountant, Exhibits
8-K 2018-05-02 Control, Officers
8-K 2018-04-20 Sale of Shares, Control, Officers
8-K 2017-11-20 Accountant

Yinghong Guangda Technology Financials

UBLI Metrics, Comps, Filings

Annual | Quarterly

Business

Item 1. Description of Business

This annual report on Form 10-K is a comprehensive filing for the fiscal years ended September 30, 2017, 2016 and 2015. It is being filed by us to move toward becoming current in our filing obligations under the Securities Exchange Act of 1934, as amended. This is our first periodic filing since we filed a Form 10-Q for the quarter ended June 30, 2015, on August 24, 2015. Included in this report are the audited financial statements that would have been included in annual reports on Form 10-K which were not previously filed for the years ended September 30, 2017, 2016 and 2015, as well as summarized quarterly financial information which would have been included in quarterly reports on Form 10-Q, which were not previously filed for each of the quarters ended December 31, 2015, 2016 and 2017, March 31, 2016 and 2017, and June 30, 2016 and 2017.

Our delinquencies with regard to these filings were due to the fact that the Company discontinued operations after June 30, 2015, because the Company's prior business plan proved to not be viable and the Company was not able to generate cash flows sufficient to continue operations, and subsequently certain of the Company's creditors sued the Company, obtained default judgements and put the Company into receivership.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
TELA Bio (TELA)
GigCapital2 (GIX)
FinServ Acquisition (FSRVU)
Afya (AFYA)
So-Young (SY)
Omni Shrimp (OMSH)
GSX Techedu (GSX)
UP Fintech (TIGR)
MabVax Therapeutics (MBVXQ)
Jiayin Group (JFIN)
TFF Pharmaceuticals (TFFP)
DouYu (DOYU)
Galileo Acquisition (GLEO)
Sirva (SRVA)
Tuscan Holdings (THCB)
PropTech Acquisition Corp (PTACU)
Adhera Therapeutics (ATRX)
Inspyr Therapeutics (NSPX)
PURE Bioscience (PURE)
Futu (FHL)

Balance Sheet ($'000)2013-09-302014-09-30
Cash126736
Accounts Receivable3151,090
Inventory
PP&E7943
Assets9524,462
Accounts Payable
Long-Term Debt4981,020
Liabilities5,1069,129
Stockholders' Equity-4,154-4,667
Income Statement ($'000)2013-09-302014-09-30
Revenue3,4304,927
Cost of Revenue1,3992,182
Gross Profit2,0322,746
R&D685493
SG&A1111,043
Tax00
Net Income-1,961-1,332
Cash Flow ($'000)2013-09-302014-09-30
Cash Operating-41378
Cash Investing-17-30
Cash Financing429563